Evidence map›Paper›PMID 36828816›Full record

ArticleNature communications2023

An analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray in rats.

Mai Iwasaki, Arthur Lefevre, Ferdinand Althammer, Etienne Clauss Creusot, Olga Łąpieś, Hugues Petitjean, Louis Hilfiger, Damien Kerspern, Meggane Melchior, Stephanie Küppers and 21 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Hypothalamic and sex-related hormones in migraine.The journal of headache and pain · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Chemoarchitectural studies of the rat hypothalamus and zona incerta.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 5 institutions in 4 countries.

Mai Iwasaki *Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Arthur Lefevre *Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.ORCID 0000-0003-2847-0859
Ferdinand Althammer *Department of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.
Etienne Clauss Creusot *Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Olga ŁąpieśCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.ORCID 0000-0001-5496-6247
Hugues PetitjeanCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Louis HilfigerCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.ORCID 0000-0002-2495-7849
Damien KerspernCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Meggane MelchiorCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Stephanie KüppersDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.ORCID 0000-0002-9004-7405
Quirin KrabichlerDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.ORCID 0000-0003-1431-5591
Ryan PatwellDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.ORCID 0000-0002-1885-1634
Alan KaniaDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.ORCID 0000-0002-3823-6196
Tim GruberVan Andel Institute, Grand Rapids, MI, USA.
Matthew K KirchnerCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, USA.ORCID 0000-0001-6960-7685
Moritz WimmerInstitute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Henning FröhlichInstitute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Laura DötschInstitute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Jonas SchimmerDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.
Sabine C HerpertzDepartment of General Psychiatry, Center of Psychosocial Medicine, University of Heidelberg, 69115, Heidelberg, Germany.
Beate DitzenInstitute of Medical Psychology, Heidelberg University Hospital, 69115, Heidelberg, Germany.
Christian P SchaafInstitute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Kai SchönigDepartment of Molecular Biology, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.
Dusan BartschDepartment of Molecular Biology, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany.
Anna GugulaDepartment of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, 30-387, Poland.ORCID 0000-0003-0045-9025
Aleksandra TrenkDepartment of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, 30-387, Poland.ORCID 0000-0002-5888-3550
Anna BlasiakDepartment of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, 30-387, Poland.ORCID 0000-0002-4017-2988
Javier E SternCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, USA.
Pascal DarbonCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France.
Valery GrinevichDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, 68159, Germany. valery.grinevich@zi-mannheim.de.ORCID 0000-0002-6337-8866
Alexandre CharletCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, 67000, Strasbourg, France. acharlet@unistra.fr.ORCID 0000-0003-4837-3706
Heidelberg University · DEInstitut des Neurosciences Cellulaires et Intégratives · FRGeorgia State University · USJagiellonian University · PLVan Andel Institute · US

Funding

Altered CNS Intercellular Signaling Mechanisms in Cardiovascular DiseaseR01HL090948 · NHLBI · UNIVERSITY OF CINCINNATI · PI STERN, JAVIER E · 2008 to 2017
$3.0M
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASISR01NS094640 · NINDS · GEORGIA STATE UNIVERSITY · PI STERN, JAVIER E · 2016 to 2020
$1.4M
NHLBI NIH HHS R01 HL090948NINDS NIH HHS R01 NS094640
6 · The paper itself

Abstract

The hypothalamic neuropeptide oxytocin (OT) exerts prominent analgesic effects via central and peripheral action. However, the precise analgesic pathways recruited by OT are largely elusive. Here we discovered a subset of OT neurons whose projections preferentially terminate on OT receptor (OTR)-expressing neurons in the ventrolateral periaqueductal gray (vlPAG). Using a newly generated line of transgenic rats (OTR-IRES-Cre), we determined that most of the vlPAG OTR expressing cells targeted by OT projections are GABAergic. Ex vivo stimulation of parvocellular OT axons in the vlPAG induced local OT release, as measured with OT sensor GRAB. In vivo, optogenetically-evoked axonal OT release in the vlPAG of as well as chemogenetic activation of OTR vlPAG neurons resulted in a long-lasting increase of vlPAG neuronal activity. This lead to an indirect suppression of sensory neuron activity in the spinal cord and strong analgesia in both female and male rats. Altogether, we describe an OT-vlPAG-spinal cord circuit that is critical for analgesia in both inflammatory and neuropathic pain models.

Indexed as

NeuralgiaOxytocinAnalgesicsAnimalsFemaleMaleNeuronsPeriaqueductal GrayRatsAnalgesicsOxytocin

Identifiers

PMID36828816
PMCPMC9958129
OpenAlexW4321783330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.